Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure	Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Enrolling by invitation	Phase 2	2026-09-10		NCT07813390

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dongguan Kanghua Hospital	3
First Affiliated Hospital of Shantou University Medical College	8
Guangdong Second Provincial General Hospital	22
Guangzhou First People's Hospital	32
Huizhou First Hospital	1
Jiangmen Central Hospital	27
Nanfang Hospital, Southern Medical University	248

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guangdong Second Provincial General Hospital	Guangzhou	China	7